Company Search:
Advanced Search
Sponsored Links
Concordia International Corp Company Snapshot
Concordia International Corp operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Concordia International Corp with three other pharmaceutical manufacturers in North America: 3sbio Inc of the United States (2017 sales of $554.47 million of which 100% was Pharmaceutical), Lannett Company, Inc. of the United States ($637.34 million of which 100% was Generic Pharmaceutical), and Emergent BioSolutions, Inc. which is also based in the United States ($560.87 million ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Concordia International Corp
  Stock Performance Chart for Concordia International Corp
  Stock Data: Recent Stock Performance:
  Current Price (5/18/2018): .37
(Figures in Canadian Dollars)
1 Week -1.3%   13 Weeks -41.3%  
4 Weeks -58.9%   52 Weeks -79.1%  
Concordia International Corp Key Data:
  Ticker: CXR Country: Canada
  Exchanges: VEN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 810,920,163
(Year Ending Jan 2018).
Employees: N/A
  Currency: Canadian Dollars Market Cap: 18,974,922
  Fiscal Yr Ends: December Shares Outstanding: 51,283,574
  Share Type: Common Closely Held Shares: 80,561
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.